Expression of a recombinant high affinity IgG Fc receptor by engineered NK cells as a docking platform for therapeutic mAbs to target cancer cells

Supporters

Support the authors with ResearchCoin

Tip RSC

Preprint Server

Topics

Biology

Cancer Oncology

Chemistry

Immunology

Antibody-Dependent Cell-Mediated Cytotoxicity

Show all topics

DOI

10.1101/432849

License

cc-no